Early research (Phase 1)Looking for participantsNCT07313813
What this trial is testing
Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company 20